Social Anxiety Disorder

Reimbursement: Up to £2510, plus reasonable travel expenses reimbursed.

About This clinical research study

MAC Clinical Research are currently conducting a clinical trial to evaluate an investigational medicine to potentially treat symptoms of Social Anxiety Disorder (SAD). SAD is a mental health condition that causes an overwhelming fear of social situations, which can affect work, personal and social lives. If you struggle with social anxiety, then you are not alone as many others are also affected by it too.

Reimbursement: Up to £2510, plus reasonable travel expenses reimbursed.

Clinics

Greater Manchester, Lancashire, Merseyside, South Staffordshire, South Yorkshire, Teesside and West Yorkshire

Therapy Area

Mental Health

Gender and Age

Males and Females aged 18 - 65

To be eligible for this clinical trial you need to have a diagnosis of Social Anxiety from your GP or Health Team. You will need to be otherwise healthy. Restrictions may apply depending on your medical history.

Reimbursement: Up to £2510, plus reasonable travel expenses reimbursed.

Key Inclusion Criteria

Key Exclusion Criteria

Other eligibility criteria will apply. Please contact MAC for more information.

Eligible participants will receive a comprehensive health screen and study participation will be in collaboration with the participant’s treating physician.

If you would like more information, please fill in the form below and we will be in touch…

Alternatively, please call our recruitment team on freephone 0800 633 5507.

  • This field is hidden when viewing the form
  • This field is hidden when viewing the form
  • This field is hidden when viewing the form
    (You can enter any supporting information here)
  • This field is hidden when viewing the form
  • This field is hidden when viewing the form
  • This field is hidden when viewing the form
  • This field is hidden when viewing the form
  • This field is hidden when viewing the form
Data Privacy Statement

Know someone who may be interested in taking part? Share this page here:

Facebook
Twitter
WhatsApp
Email